Pharmacosmos ventures into oncology and merges with G1 Therapeutics
Pharmacosmos will secure its second FDA-approved drug and first oncology therapy, G1 Therapeutics’ Costela as part of the merger.
Pharmacosmos will secure its second FDA-approved drug and first oncology therapy, G1 Therapeutics’ Costela as part of the merger.
What's Your Reaction?
